LOXL2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

DNA lentivector for transduction information

Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression. This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions. GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, our 3rd Generation Packaging mixture. pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C. Vectors with selection markers like kanamycin, puromycin or cumate are available.
Lentiviral technical files
Lentivirus references
Properties

Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Gene target

LOXL2 Lentiviral Vector UbC pLenti-GIII-UbC
Gene symbol

PLA2G3, LOXL2
Short name

LOXL2 Lentiviral Vector ( ) (UbC) (pLenti-GIII-UbC)
Technique

Vectors
Species

Human, Humans
Alternative name

lysyl oxidase-like 2 Lentiviral integrating Desoxyribonucleic acid sequence (H. sapiens) (UbC) (pLenti-GIII-UbC)
Alternative to gene target

lysyl oxidase-like 2, LOR2 and WS9-14, LOXL2 and IDBG-11841 and ENSG00000134013 and 4017, oxidoreductase activity, nuclei, Loxl2 and IDBG-177377 and ENSMUSG00000034205 and 100862072,94352, LOXL2 and IDBG-635071 and ENSBTAG00000006214 and 532684

Name

Cloning, Molecular
Concept

Scope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
Tree numbers
- E05.393.220
Qualifiers

drug effects, methods, radiation effects